Cao Luong Dong, Naruhiko Ishiwada, Nobue Takeda, Yoichi Kohno
Department of Pediatrics, Graduate School of Medicine Chiba University, Chiba, Japan.
Pediatr Int. 2004 Aug;46(4):419-24. doi: 10.1111/j.1442-200x.2004.01928.x.
Haemophilus influenzae (H. influenzae) is the most frequent bacterial pathogen of respiratory tract infections in children. Detection of antimicrobial susceptibility of H. influenzae is necessary for institution of appropriate antibiotic treatments.
A total of 281 strains of H. influenzae isolated from sputum samples of 281 pediatric patients with respiratory tract infections were recruited for study. Antibiotic susceptibility was determined by assessing minimum inhibitory concentrations (MIC) of antimicrobial agents. MIC were measured by utility of Agar dilution susceptibility test.
Of the total, 38 (13.5%) strains produced beta-lactamase (BLP), 56 (19.9%) strains were beta-lactamase non-producing, ampicillin resistant (BLNAR). The overall resistant proportion to ampicillin was 33.4%. The data indicated that sulbactam/ampicillin, cefotaxime, ceftriaxone and cefditoren are effective against BLP strains. In addition, a high prevalence of BLNAR H. influenzae strains was identified, with an overall isolation rate of 19.9%. Those strains mainly demonstrated intermediate level to ampicillin (ampicillin-MIC </= 3.13 micro g/mL for most of BLNAR strains). However, antimicrobial activities of cefotaxime, ceftriaxone and cefditoren against those strains were slightly diminished. Recovery rate of BLP strains was varied by years, peaking at 19.5%. In particular, a trend of yearly increase in frequency of BLNAR strains was observed.
Frequency of BLNAR strains causing respiratory infections has been dramatically increasing, which can diminish antibiotic activities of not only ampicillin but also of some cephems.
流感嗜血杆菌是儿童呼吸道感染中最常见的细菌病原体。检测流感嗜血杆菌的抗菌药敏情况对于制定合适的抗生素治疗方案很有必要。
共纳入了281例呼吸道感染儿科患者痰液样本中分离出的281株流感嗜血杆菌进行研究。通过评估抗菌药物的最低抑菌浓度(MIC)来确定抗生素敏感性。MIC采用琼脂稀释药敏试验进行测定。
总共38株(13.5%)产生β-内酰胺酶(BLP),56株(19.9%)为不产β-内酰胺酶但对氨苄西林耐药(BLNAR)。对氨苄西林的总体耐药率为33.4%。数据表明,舒巴坦/氨苄西林、头孢噻肟、头孢曲松和头孢地尼对BLP菌株有效。此外,还发现BLNAR流感嗜血杆菌菌株的高流行率,总体分离率为19.9%。这些菌株对氨苄西林主要表现为中介水平(大多数BLNAR菌株的氨苄西林-MIC≤3.13μg/mL)。然而,头孢噻肟、头孢曲松和头孢地尼对这些菌株的抗菌活性略有降低。BLP菌株的回收率随年份有所不同,峰值为19.5%。特别是,观察到BLNAR菌株的频率呈逐年上升趋势。
引起呼吸道感染的BLNAR菌株频率一直在急剧增加,这不仅会降低氨苄西林的抗菌活性,还会降低一些头孢菌素的抗菌活性。